R. Hauser

470 total citations
18 papers, 332 citations indexed

About

R. Hauser is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, R. Hauser has authored 18 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 4 papers in Cellular and Molecular Neuroscience and 2 papers in Cognitive Neuroscience. Recurrent topics in R. Hauser's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (11 papers) and Parkinson's Disease and Spinal Disorders (2 papers). R. Hauser is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (11 papers) and Parkinson's Disease and Spinal Disorders (2 papers). R. Hauser collaborates with scholars based in United States, Canada and Austria. R. Hauser's co-authors include Theresa A. Zesiewicz, Peter B. Dunne, Cynthia R. Cimino, Theresa Zesiewicz, Kelly L. Sullivan, Geetha Chari, M. Gold, Ali Malek, Paul Leaverton and Thomas B. Freeman and has published in prestigious journals such as Neurology, Movement Disorders and Journal of the Neurological Sciences.

In The Last Decade

R. Hauser

18 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Hauser United States	10	191	75	63	55	51	18	332
Huidan Weng China	12	112 0.6×	29 0.4×	35 0.6×	40 0.7×	23 0.5×	15	298
Chuang‐Kuo Wu United States	5	30 0.2×	61 0.8×	44 0.7×	2 0.0×	36 0.7×	13	198
Ariane Park United States	7	252 1.3×	71 0.9×	52 0.8×	44 0.8×	62 1.2×	8	379
S. Pohle Germany	4	166 0.9×	64 0.9×	56 0.9×	10 0.2×	40 0.8×	4	275
Chizoba C. Umeh United States	10	215 1.1×	76 1.0×	23 0.4×	33 0.6×	36 0.7×	18	329
Liis Kadastik‐Eerme Estonia	12	250 1.3×	52 0.7×	24 0.4×	41 0.7×	35 0.7×	16	352
Jerry L. Morris United States	9	268 1.4×	72 1.0×	7 0.1×	31 0.6×	68 1.3×	14	365
Alfonso Rubino Italy	10	252 1.3×	76 1.0×	18 0.3×	37 0.7×	47 0.9×	22	349
Téodor Danaila France	11	238 1.2×	66 0.9×	32 0.5×	28 0.5×	58 1.1×	27	342
Gail A. Kang United States	12	571 3.0×	249 3.3×	35 0.6×	21 0.4×	94 1.8×	16	716

Countries citing papers authored by R. Hauser

Since Specialization

Citations

This map shows the geographic impact of R. Hauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hauser more than expected).

Fields of papers citing papers by R. Hauser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Hauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hauser. The network helps show where R. Hauser may publish in the future.

Co-authorship network of co-authors of R. Hauser

This figure shows the co-authorship network connecting the top 25 collaborators of R. Hauser. A scholar is included among the top collaborators of R. Hauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Hauser. R. Hauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Hauser, R., et al.. (2024). The ligamentous cervical instability etiology of human disease from the forward head-facedown lifestyle: emphasis on obstruction of fluid flow into and out of the brain. Frontiers in Neurology. 15. 1430390–1430390. 5 indexed citations

Hauser, R., Mark Lew, Cynthia L. Comella, et al.. (2020). Nighttime and morning OFF improvements with opicapone in patients with Parkinson's Disease and motor fluctuations: BIPARK-1 and BIPARK-2 pooled subanalyses. Parkinsonism & Related Disorders. 79. e53–e54. 2 indexed citations

Hauser, R., Olivier Rascol, Werner Poewe, et al.. (2019). Opicapone as a levodopa sparing agent: Pooled analysis of BIPARK-I and II double-blind trials. Journal of the Neurological Sciences. 405. 218–219. 3 indexed citations

Poewe, W., Paolo Barone, R. Hauser, et al.. (2011). 2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE. Parkinsonism & Related Disorders. 18. S131–S132. 1 indexed citations

Hauser, R., et al.. (2009). P2.109 Piclozotan reduces dyskinesia and OFF time in Parkinson's disease (PD) patients with L-dopa induced motor complications. Parkinsonism & Related Disorders. 15. S118–S118. 5 indexed citations

Rascol, Olivier, Paolo Barone, R. Hauser, et al.. (2009). P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage. Parkinsonism & Related Disorders. 15. S131–S132. 1 indexed citations

Schapira, Anthony H.V., Paolo Barone, R. Hauser, et al.. (2009). P2.159 Efflcacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease. Parkinsonism & Related Disorders. 15. S133–S133. 1 indexed citations

Zesiewicz, Theresa A., et al.. (2007). Social Security Disability Insurance (SSDI) in Parkinson's disease. Disability and Rehabilitation. 29(24). 1934–1936. 28 indexed citations

Simonson, William, R. Hauser, & Anthony H.V. Schapira. (2007). Role of the Pharmacist in the Effective Management of Wearing-Off in Parkinson's Disease. Annals of Pharmacotherapy. 41(11). 1842–1849. 11 indexed citations

10.

Zesiewicz, Theresa, Joel A. Strom, Amy R. Borenstein, et al.. (2004). Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey. Parkinsonism & Related Disorders. 10(7). 417–420. 49 indexed citations

11.

Zesiewicz, Theresa A., Cynthia R. Cimino, Ali Malek, et al.. (2002). Driving safety in Parkinson’s disease. Neurology. 59(11). 1787–1788. 73 indexed citations

12.

Freeman, Thomas B., R. Hauser, Paul R. Sanberg, & Samuel Saporta. (2000). Chapter 18 Neural transplantation for the treatment of Huntington's disease. Progress in brain research. 127. 405–411. 25 indexed citations

13.

Hauser, R., et al.. (2000). Modafinil treatment of pramipexole-associated somnolence. Movement Disorders. 15(6). 1269–1271. 36 indexed citations

14.

Zesiewicz, Theresa A., M. Gold, Geetha Chari, & R. Hauser. (1999). Current issues in depression in Parkinson's disease.. PubMed. 7(2). 110–8. 45 indexed citations

15.

Hauser, R. & Theresa A. Zesiewicz. (1999). MANAGEMENT OF EARLY PARKINSON'S DISEASE. Medical Clinics of North America. 83(2). 393–414. 9 indexed citations

16.

Hauser, R., Theresa A. Zesiewicz, Stewart A. Factor, Mark Guttman, & William J. Weiner. (1997). Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness. Parkinsonism & Related Disorders. 3(1). 1–6. 3 indexed citations

17.

Borlongan, Cesar V., Thomas B. Freeman, R. Hauser, David W. Cahill, & Paul R. Sanberg. (1996). Cyclosporine-A increases locomotor activity in rats with 6-hydroxydopamine-induced hemiparkinsonism: Relevance to neural transplantation. Surgical Neurology. 46(4). 384–388. 18 indexed citations

18.

Woodward, William R., C. Warren Olanow, R. Hauser, et al.. (1993). The effect of L‐dopa infusions with and without phenylalanine challenges in parkinsonian patients. Neurology. 43(9). 1704–1704. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact